ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,311.45
0.06%
Dow Jones
39,856.80
0.13%
US Dollar vs MXN
16.5649
0.06%
Brent Oil
83.00
-0.63%
Bitcoin
70,466.73
-1.36%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Perrigo Company Plc Ireland (PRGO)

  7. Perrigo Company Plc Ireland (PRGO) Noticias

PRGO

Perrigo Company Plc Irel... (PRGO)

Perrigo Company Plc Ireland
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:PRGO
FechaHoraFuenteTítuloSímboloCompañía
16/05/202418:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PRGOPerrigo Company Plc Ireland
07/05/202409:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:PRGOPerrigo Company Plc Ireland
07/05/202405:44Edgar (US Regulatory)Form 8-K - Current reportNYSE:PRGOPerrigo Company Plc Ireland
07/05/202405:31PR Newswire (US)Perrigo Reports First Quarter 2024 Financial Results From Continuing OperationsNYSE:PRGOPerrigo Company Plc Ireland
07/05/202405:28PR Newswire (US)Perrigo Announces Executive Transition for its Consumer Self-Care International (CSCI) BusinessNYSE:PRGOPerrigo Company Plc Ireland
01/05/202408:42PR Newswire (US)Perrigo Announces Quarterly DividendNYSE:PRGOPerrigo Company Plc Ireland
25/04/202405:00PR Newswire (US)Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 MillionNYSE:PRGOPerrigo Company Plc Ireland
23/04/202407:09PR Newswire (US)Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024NYSE:PRGOPerrigo Company Plc Ireland
09/04/202411:30PR Newswire (US)Opill and WNBA Team Up for Groundbreaking PartnershipNYSE:PRGOPerrigo Company Plc Ireland
07/03/202420:47Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:PRGOPerrigo Company Plc Ireland
04/03/202407:00PR Newswire (US)Perrigo Commences Shipments of Opill® to Retailers Nationwide, Empowering Millions to Enter a New Era of Reproductive Health Access in the United StatesNYSE:PRGOPerrigo Company Plc Ireland
29/02/202415:21PR Newswire (US)Perrigo to Attend UBS Global Consumer and Retail ConferenceNYSE:PRGOPerrigo Company Plc Ireland
27/02/202416:05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:PRGOPerrigo Company Plc Ireland
27/02/202405:30PR Newswire (US)Perrigo Reports Fourth Quarter & Fiscal Year 2023 Financial Results From Continuing Operations; Launches Investment & Efficiency ProgramNYSE:PRGOPerrigo Company Plc Ireland
26/02/202415:30PR Newswire (US)Perrigo Increases its Quarterly DividendNYSE:PRGOPerrigo Company Plc Ireland
13/02/202407:16PR Newswire (US)Perrigo to Release Fourth Quarter and Fiscal Year 2023 Financial Results on February 27, 2024NYSE:PRGOPerrigo Company Plc Ireland
11/01/202412:58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:PRGOPerrigo Company Plc Ireland
29/11/202307:54PR Newswire (US)Perrigo Announces Early Results of Cash Tender Offer for NotesNYSE:PRGOPerrigo Company Plc Ireland
10/11/202308:16PR Newswire (US)Perrigo Announces Cash Tender Offer for NotesNYSE:PRGOPerrigo Company Plc Ireland
09/11/202308:32Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:PRGOPerrigo Company Plc Ireland
07/11/202305:30PR Newswire (US)Perrigo Reports Third Quarter Fiscal Year 2023 Financial Results From Continuing OperationsNYSE:PRGOPerrigo Company Plc Ireland
31/10/202307:54PR Newswire (US)Perrigo to Attend Upcoming Consumer Investor ConferencesNYSE:PRGOPerrigo Company Plc Ireland
24/10/202308:54PR Newswire (US)Perrigo to Release Third Quarter 2023 Financial Results on November 7, 2023NYSE:PRGOPerrigo Company Plc Ireland
11/09/202315:05PR Newswire (US)Perrigo Announces Leadership UpdateNYSE:PRGOPerrigo Company Plc Ireland
30/08/202316:27Dow Jones NewsFDA Warns Three Baby-Formula Makers Over Violations in ProductionNYSE:PRGOPerrigo Company Plc Ireland
08/08/202305:30PR Newswire (US)Perrigo Reports Second Quarter Fiscal Year 2023 Financial Results From Continuing OperationsNYSE:PRGOPerrigo Company Plc Ireland
02/08/202309:19PR Newswire (US)PERRIGO ANNOUNCES QUARTERLY DIVIDENDNYSE:PRGOPerrigo Company Plc Ireland
25/07/202308:31PR Newswire (US)Perrigo to Release Second Quarter 2023 Financial Results and Present at an Industry Growth ConferenceNYSE:PRGOPerrigo Company Plc Ireland
14/07/202306:51IH Market NewsFriday’s Wall Street Highlights: JPMorgan Chase, Coinbase, UPS, Theseus Pharmaceuticals, and moreNYSE:PRGOPerrigo Company Plc Ireland
13/07/202308:25Dow Jones NewsPerrigo Says FDA Approved Its Oral Contraceptive Pill for OTC UseNYSE:PRGOPerrigo Company Plc Ireland
 Showing the most relevant articles for your search:NYSE:PRGO

Su Consulta Reciente

USOTC
PRRCF
Procredit (PK)
USOTC
FLKI
Falken Industries (CE)
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados